- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Budesonide with eformoterol – July 2017
Budesonide with eformoterol: Powder for oral inhalation in breath actuated device, 120 doses; DuoResp®, Spiromax
Last updated
10 November 2017